spacer

International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
 
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
 
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
 
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
 
eClinical Technologies
The Long Road to eSource

Since the introduction of electronic diaries in the early 2000s, eSource has provided an excellent opportunity to not only streamline clinical research, but increase data quality and trustworthiness

Rebecca D Kush at Elligo Health Research
 
Features
Base Editing and Its Application to Cell and Gene Therapy

Dr Ceri Wiggins at Horizon Discovery

CRISPR-Cas gene editing has been a force to be reckoned with in gene engineering for years, and it doesn’t seem likely this is going to change anytime soon
 
Sustainability in Pharma
Preparing for a World in Flux

Rich Quelch at Origin

The pharma industry is part of the problem, but it can also be a part of the solution when it comes to minimising climate change.

 

 

Website design and development by Rubler Studio
spacer

Member login

E-mail address:

Password:
Remember me

.
News and Press Releases

Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino

Vilnius, Lithuania, and Copenhagen, Denmark – December 18th 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >>

.
White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>



Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement